Daniel Paterson has been leading Verastem, Inc. as CEO since August 2023. He’s legit been in the game for a while, moving up the ranks through various key roles. Before taking the reins at Verastem, he was the COO and...
Daniel Paterson has been leading Verastem, Inc. as CEO since August 2023. He’s legit been in the game for a while, moving up the ranks through various key roles. Before taking the reins at Verastem, he was the COO and has worked in executive positions at other biotech firms. His rich experience includes time at On-Q-ity and The DNA Repair Company, which was a big player before its acquisition. Paterson’s got a solid business background, which helps steer Verastem in the competitive landscape of healthcare. In 2023, his total compensation hit about $2.82 million, a mix of salary, bonus, and vested stock options. He’s also known for making significant moves in the stock market; his insider trading history shows he had some pretty strong transactions back in 2020, peaking at over $2 million in a single month. Paterson’s commitment to the company shines through, aligning his benefits with Verastem's performance goals. He’s driven by results and aims to create real value for the company and its stakeholders.